Market open
Apyx Medical/$APYX
Apyx Medical shares are trading higher after receiving FDA clearance for its AYON Body Contouring System.
4 hours ago·Lightyear AI
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Apyx Medical
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
Ticker
$APYX
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
220
ISIN
US03837C1062
Website
Apyx Medical Metrics
BasicAdvanced
$56M
-
-$0.54
1.12
-
Price and volume
Market cap
$56M
Beta
1.12
52-week high
$1.81
52-week low
$0.76
Average daily volume
331K
Financial strength
Current ratio
5.452
Quick ratio
4.485
Long term debt to equity
362.101
Total debt to equity
365.614
Interest coverage (TTM)
-2.60%
Management effectiveness
Return on assets (TTM)
-14.60%
Return on equity (TTM)
-129.51%
Valuation
Price to revenue (TTM)
1.168
Price to book
5.32
Price to tangible book (TTM)
5.32
Growth
Revenue change (TTM)
-6.27%
Earnings per share change (TTM)
-18.44%
3-year revenue growth (CAGR)
-3.35%
3-year earnings per share growth (CAGR)
4.41%
What the Analysts think about Apyx Medical
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Apyx Medical stock.
Apyx Medical Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Apyx Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Apyx Medical News
AllArticlesVideos
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
GlobeNewsWire·3 days ago
Apyx Medical Corporation (APYX) Q1 2025 Earnings Call Transcript
Seeking Alpha·5 days ago
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Apyx Medical stock?
Apyx Medical (APYX) has a market cap of $56M as of May 16, 2025.
What is the P/E ratio for Apyx Medical stock?
The price to earnings (P/E) ratio for Apyx Medical (APYX) stock is 0 as of May 16, 2025.
Does Apyx Medical stock pay dividends?
No, Apyx Medical (APYX) stock does not pay dividends to its shareholders as of May 16, 2025.
When is the next Apyx Medical dividend payment date?
Apyx Medical (APYX) stock does not pay dividends to its shareholders.
What is the beta indicator for Apyx Medical?
Apyx Medical (APYX) has a beta rating of 1.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.